SCHEMBL28265661

SCHEMBL28265661

COc1ccc(-c2nc(N)nc(N)c2C(C)(C)C)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 2/20 0.55
▸ ADORA2A P29274 2/20 0.52
▸ KMT2A Q03164 1/20 0.51
▸ HRH3 Q9Y5N1 3/20 0.50
▸ HRH2 P25021 2/20 0.50
▸ DHFR P00374 1/20 0.49
▸ HEXA P06865 1/20 0.49
▸ HEXB P07686 1/20 0.49
▸ KDM4E B2RXH2 2/20 0.46
▸ ALDH1A1 P00352 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ ATM Q13315 1/20 0.46
▸ DYRK1A Q13627 1/20 0.46
▸ PDCD1 Q15116 1/20 0.46
▸ CD274 Q9NZQ7 1/20 0.46
▸ TP53 P04637 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ HTT P42858 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28265800 0.81 SMN1; SMN2 (0.46) ADORA1ADORA2AKMT2AHRH3HRH2
SCHEMBL4416122 0.79 ADORA1 (0.59) ADORA1ADORA2AKMT2AHRH3HRH2
SCHEMBL31256308 0.76 ADORA1 (0.52) ADORA1ADORA2AKMT2AHRH3HRH2
SCHEMBL28151079 0.73 ADORA1 (0.52) ADORA1ADORA2AKMT2AHRH3HRH2
SCHEMBL6700778 0.72 KMT2A (0.54) ADORA1ADORA2AKMT2AHRH3HRH2
SCHEMBL30412772 0.71 ADORA1 (0.67) ADORA1ADORA2AKMT2AHRH3HRH2
SCHEMBL979446 0.71 ADORA1 (0.67) ADORA1ADORA2AKMT2AHRH3HRH2
SCHEMBL1892740 0.71 ADORA2A (0.59) ADORA1ADORA2AKMT2AHRH3HRH2
SCHEMBL11372127 0.71 DHFR (0.73) ADORA1ADORA2AKMT2AHRH3HRH2
SCHEMBL28957216 0.71 LMNA (0.44) KMT2ADHFRHEXAHEXBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105143206-B Pyrimidine -2,4- diamine derivative for treating cancer 托马斯·黑勒戴药物研究基金会 2019-01-15 — — CN disclosed
Send feedback